Gainers Evelo Biosciences, Inc. (NASDAQ: EVLO) jumped 147.9% to $0.2479. Evelo Biosciences shares dropped 33% on Wednesday after the company announced top-line data from the fourth cohort of its EDP1815 Phase 2 trial, in which the primary endpoint was not met.
Traders across Wall Street have been gunning for a downturn in U.S. stocks, which have been surprisingly resilient in recent weeks despite numerous headwinds. On Tuesday, broad-based indices are showing some weakness while defensive sectors have been rallying modestly.
National Energy Services Reunited Corp (NASDAQ: NESR) has received multiple contract awards worth ~$100 million over three years commencing in 2022 and evenly...
The energy sector is made up of businesses that are involved in the exploration, production, and selling of oil, gas, and renewable resources all over the world. Upstream...
On Wednesday, 160 companies hit new 52-week lows.
Areas of Significance In Today's 52-Week Lows:
Walt Disney (NYSE:DIS) was the largest firm by market cap to set a new...
On Wednesday, 90 companies set new 52-week lows.
Areas of Significance In Today's 52-Week Lows:
The company with the largest market cap to set a new 52-week low was...
